Ajay Verma is EVP, Head of R&D of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 30,000 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Dec 01, 2021, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
0% 12M change
Total Value Held $0

Ajay Verma Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2021
BUY
Grant, award, or other acquisition
-
30,000 Added 50.0%
30,000 Common Stock

Also insider at

CDAK
Codiak BioSciences, Inc. Healthcare
AV

Ajay Verma

EVP, Head of R&D
Cambridge, MA

Track Institutional and Insider Activities on YMTX

Follow YUMANITY THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Track Activities on YMTX